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ABSTRACT
Objectives: To investigate whether beliefs about asthma medication, cognitive and emotional
factors are related to poor asthma control in a sample of Latvian asthma patients in 2015.
Design: Cross-sectional, self-administered survey.
Subjects: Three hundred and fifty two asthma patients (mean age 57.5 years) attending out-
patient pulmonologist consultations in Riga, Latvia during September 2013 to December 2015.
The sample size was calculated to detect a prevalence of poor asthma control of 50% with a
margin of error of 5% and a power of 95%.
Main outcome measures: The validated Beliefs about Medication Questionnaire (BMQ) and the
Brief Illness Perception Questionnaire (brief IPQ) were used. Good asthma control was assessed
using the asthma control test (ACT), a validated five-item scale that reliably assesses asthma con-
trol over a recall period of four weeks. Logistic regression models were used to predict poor
asthma control.
Results: Patients who had a good control of asthma medication (OR 0.70; 95% CI 0.61–0.79) or
were confident that their asthma medication improves illness (OR 0.84; 95% CI 0.74–0.95) had a
reduced risk of poor asthma control. The more symptoms (OR 1.63; 95% CI 1.44–1.84) the
asthma patients perceived or the more their illness affects their life, the higher the probability of
poor asthma control (OR 1.47; 95% CI 1.31–1.65). Some beliefs of necessity and concerns of
asthma medication were also statistically significantly related to poor asthma control.
Conclusions: Beliefs of necessity of asthma medication, cognitive and emotional illness percep-
tion factors correlate well with poor asthma control in Latvian patients.
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Globally, about 300 million people are suffering from
asthma, and current estimations suggest that an add-
itional 100 million people may be living with asthma
by the end of 2025 [1,2].
According to current clinical evidence, compliance
to asthma medication is poor, with reported rates of
non-compliance ranging from 30 to 70% [3–5]. There
is common agreement that low treatment adherence
explains in great parts the observed insufficient dis-
ease control in asthma patients in both Europe and
worldwide as adequate asthma control requires the
use of regular asthma medication [1,6–8]. The principal
goal of asthma treatment is to achieve adequate
asthma control in order to prevent disease progression
and functional limitations that a patient experiences
due to his disease [1,9]. In addition, good asthma
control has been shown to improve quality of life in
both children and adult patients [10–12].
One of the key roles of the healthcare professional
is to adjust asthma treatment to reach and maintain
optimal control. Generally, good control may also
depend on several other factors such as individual’s
understanding of his disease, the necessity or concerns
of the current treatment [13–15]. Especially, the neces-
sity-concern framework of the self-regulation theory
proposed may affect asthma control as an individual’s
understanding of his or her disease and its treatment
may be an important mediator of key health behav-
iours, such as medication use [16]. However, there is
limited evidence about associations between medica-
tion beliefs, illness perception and asthma control. The
few studies that have assessed one of the above men-
tioned indicators were mainly conducted to test
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associations with treatment compliance related to spe-
cific medication such as corticosteroids but not with
the control of the disease in general [17–18].
Furthermore, there is only limited information available
about treatment and control of asthma patients in the
Baltic countries such as Latvia.
The aim of this study was to investigate whether
beliefs about asthma medication, and cognitive and
emotional factors are related to good asthma control
in a sample of Latvian asthma patients in 2015.
Materials and methods
Study population
The study population of this cross-sectional patient
survey consisted of asthma patients attending out-
patient pulmonologist consultations in Riga, Latvia
during September 2013 to December 2015. Latvian
patients in most cases will receive their initial disease
diagnosis and treatment initiation in a pulmonologist
practice. They get there in larger part by a referral by
a general practitioner (GP) or alternatively by direct
patient contact. The majority of GPs refer their asthma
and COPD patients to a specialist at least once a year
for control. The role of GPs within the Latvian health
care system is mainly to ensure that a patient follows
the treatment regime set forth by the specialist. Only
patients referred by a GP to a NHS registered practice
can get their medication reimbursed by NHS. In a first
step, a list of all pulmonologists from the database of
the National Health Service (NHS) of the medical doc-
tors that have contractual rights to prescribe reim-
bursed medicines was acquired. Then, pulmonologists
in large medical centres and hospitals in Riga and in
bigger towns of Latvia were randomly selected and
invited to join the study. The total number of partici-
pating pulmonologist practices was 15. Each pulmo-
nologist was advised to invite his patients to join the
survey. The sample size was calculated to detect a
prevalence of poor asthma control of 50% with a mar-
gin of error of 5%, and a power of 95%. The total sam-
ple size needed and respectively studied was 352
people. Only patients that have been using asthma
medication for at least one year were included in this
study.
Assessment of main variables
A self-administered questionnaire was used to assess
socio-demographic and economic factors such as age,
education, income and sex. Good asthma control was
assessed using the asthma control test (ACT), a
validated five-item scale that reliably assesses asthma
control over a recall period of four weeks. The ACT
consists of the following questions: ‘How much of the
time did your asthma keep you from getting as much
done at work, school or at home?’. ‘How often have
you had shortness of breath?’. ‘How often did your
asthma symptoms wake you up at night or earlier
than usual in the morning?’, ‘How often have you
used your rescue inhaler or nebulizer medication?’ and
‘How would you rate your asthma control?’. Each item
was scaled from 1 to 5, and by summing the response
values a scale score was calculated ranging from poor
(5) to total (25) control [19,20]. ACT scores have shown
to be well correlated with baseline per cent predicted
forced expiratory volume [20].
Medication beliefs were assessed using the five
items of greatest relevance to asthma medication
adapted from the Beliefs about Medication
Questionnaire (BMQ), a validated tool across many dis-
ease conditions [21,22]. The specific–necessity scale
contains five items that assess patients’ beliefs about
specific necessity to take prescribed chronic medica-
tions. All three questions assessing patients’ beliefs
about specific necessity to take prescribed chronic
medications or concerns were selected from the ori-
ginal BMQ. All belief items had Likert scale responses.
The Brief Illness Perception Questionnaire (brief IPQ)
was used to obtain information on illness perception
of the study participants. The Brief IPQ consists of
eight items and a causal question [17,23,24]. All of the
items except the causal question are rated using a 0
to 10 response scale. Five of the items assess cognitive
illness representations: consequences (item 1), timeline
(item 2), personal control (item 3), treatment control
(item 4) and identity (item 5). Two of the items assess
emotional representations: concern (item 6) and emo-
tions (item 8). One item assesses illness comprehensi-
bility (item 7). Assessment of the causal representation
is by an open-ended response, which asks patients to
list the three most important causal factors in their ill-
ness (item 9).
Statistical analysis
The Statistical Package for the Social Sciences (SPSS)
IBM 21.0 was used to analyse the data. Means, stand-
ard deviations, and frequencies are presented to
describe the characteristics of the study sample. A cut-
off point of 19 was defined to indicate poorly con-
trolled asthma, and scores of 20 points or more corre-
sponded to well-controlled asthma [19,20]. The
answers of the BMQ were dichotomized into (i) ‘I
agree/I completely agree’ and (ii) ‘Not sure/I disagree/I
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completely disagree’ similar to the methods of previ-
ous study to ease clinical application [18,25]. The logis-
tic regression analyses were first conducted for each
variable alone. In the multivariate logistic analysis the
outcome variable was controlled for age, income and
educational level. The odds ratio (OR) and respective
95% confidence interval are presented for all models.
The OR presented in Tables 3 and 4 are for the ‘I
agree/I completely agree’ categories with the ‘Not
sure/I disagree/I completely disagree’ category as ref-
erence group. The validity of each logistic regression
model was assessed by the Hosmer/Lemeshow test.
Results
The baseline characteristics of the study population
are presented in Table 1. Among the study partici-
pants, 75% were women (n¼ 264). The majority of
the patients had at least professional education and
were earning at least 300 euros per month. Two out
of three patients were using corticosteroids and one
third a combination therapy consisting of corticoste-
roids and a beta 2 mimetic drug. The prevalence of
poor asthma control was 63% in men and 66% in
women.
Whereas age and income were predictors of poor
asthma control, educational level, use of corticoste-
roids or sex were not statistically significantly related
to poor asthma control (Table 2). An income level of
more than 300 euros/month statistically significantly
reduce the probability of having asthma poorly con-
trolled compared to the <300 euro/month patient
group. The corresponding OR were 0.39 (300–550
euros/month), 0.28 (550/750 euros/month) and 0.24
(>750 euros/month), respectively.
Table 3 shows the results of the logistic regression
analysis of the different beliefs about medicines in
regard of poor asthma control. Agreement on neces-
sity of asthma medication was statistically significantly
related to an increase in the odds of poor asthma
control. The increase in risk of poor asthma control
was almost three-fold in patients who were con-
vinced that their life fully depends on their medica-
tion (OR 2.89; 95% CI 1.78–4.71). In addition, beliefs
such as ‘without asthma medication life would be
impossible’ (OR 2.69; 95% CI 1.56–4.12) or ‘without
asthma medication the patient would be very ill’ (OR
2.69; 95% CI 1.66–4.38) were significantly related to
poor asthma control after adjustment for age, educa-
tion and income. Finally, if the patient was concerned
by the need to use his asthma medication constantly,
the probability of poor asthma control doubled (OR
1.94; 95% CI 1.19–3.17) compared to those without
concerns. Neither were concerns regarding long-term
use nor understanding of ones asthma medication
statistically significantly related with poor asthma
control.
Several cognitive and emotional illness indicators
predicted poor asthma control in the study patients
regardless of controlling for other covariates
(Table 4). The more the asthma patients perceived
that their illness affect their life, the higher the prob-
ability of poor asthma control (OR 1.47; 95% CI
1.31–1.65). On one hand, estimated duration, concern
and emotional affection of asthma increased the
odds of poor asthma control. On the other, a better
self-perception of asthma control (OR 0.7; 95% CI
0.61–0.79) or considering that the current treatment
is helpful (OR 0.84; 95% CI 0.74–0.95) were related
to improved asthma control. Understanding their
Table 1. Baseline characteristics of the study sample.
Men Women Total
(n¼ 85) (n¼ 264) (n¼ 352)
Age, mean (SD) 53.7 (17.4) 58.7 (16.6) 57.5 (16.9)
Education, %
Basic 3.5 7.5 6.5
Secondary 23.3 27.1 26.1
Professional 47.7 28.9 33.5
Highera 25.6 36.5 33.8
Income, %
<300 e/month 16.7 25.3 23.2
300–550 e/month 36.9 48.2 45.5
550–750 e/month 28.6 18.3 20.8
>750 e/month 17.9 8.2 10.6
Asthma medication, %




Poor asthma controlb, % 62.8 66 65.3
aBachelor, masters and PhD levels.
bACT score19.
Table 2. Odds ratio of sociodemographic and socio-economic




Female sex 1.15 (0.70–1.91)
Educationc




<300 e/month 1 ref.
300–550 e/month 0.39 (0.20–0.76)
550–750 e/month 0.28 (0.13–0.59)
>750 e/month 0.24 (0.10–0.58)
Asthma medication
Inhaled corticosteroids 0.94 (0.60–1.48)
Inhaled corticosteroidsþ beta 2 mimetic 1.33 (0.83–2.13)
aOdds ratio.
bConfidence interval.
cBachelor, masters and PhD levels.
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illness did not affect asthma control in the study
population.
Discussion
Our study showed that some beliefs of necessity of
asthma medication as well as cognitive and emotional
illness perception factors correlate well with poor
asthma control in Latvian patients. Naturally, our study
had some limitations. Asthma control was measured
by a self-report questionnaire not previously validated
in the Latvian population. Clinical measurements of
asthma control may be more precise and objective.
However, the ACT has been successfully validated in
other studies consisting of a similar population to ours
and has shown to be well correlated with baseline per
cent predicted forced expiratory volume [20]. Thus,
the ACT may correlate well with forced expiratory vol-
ume in the Latvian population as well. In addition, as
this study is cross-sectional in design, no conclusions
on causality can be drawn. Finally, even though the
patients of this study were recruited from the main
towns and the capital city where the majority of the
Latvian population live, the results cannot be general-
ized to the overall population of Latvian asthma
patients.
Guideline-defined asthma control can be attained
and maintained for the majority of patients in con-
trolled research settings, but current evidence indi-
cates that many asthmatic patients do not achieve an
acceptable asthma control in real-life clinical practice
[9,26,27]. In our study, two out of three patients had
poor asthma control measured by the ACT. Even
though assessing asthma control with only symptoms
and not clinical measurements usually overestimates
the result, our estimates of poor asthma control is in
line with previous findings from European studies
revealing a prevalence of 49–76% of poor asthma con-
trol in various European populations [7,8,28–30]. The
AIRE study conducted in seven European countries
(France, Germany, Italy, The Netherlands, Spain,
Sweden and UK) showed that just 5.3% of all patients
in European countries met all the GINA criteria for
asthma control. 46% of patients reported daytime
symptoms and 30% asthma-related sleep disturbances
at least once a week [7]. A Spanish study on the other
Table 4. Odds ratio of each of the eight items of the cognitive and emotional illness questionnaire in regard probability of poor
asthma control.
Univariate Multivariatea
ORb (95% CIc) OR (95% CI)
How much does your illness affect your life? 1.46 (1.32–1.62) 1.47 (1.31–1.65)
How long do you think your illness will continue? 1.14 (1.05–1.25) 1.16 (1.05–1.27)
How much control do you feel you have over your illness? 0.69 (0.62–0.78) 0.70 (0.61–0.79)
How much do you think your treatment can help your illness? 0.84 (0.75–0.95) 0.84 (0.74–0.95)
How much do you experience symptoms from your illness? 1.65 (1.47–1.85) 1.63 (1.44–1.84)
How concerned are you about your illness? 1.24 (1.15–1.34) 1.23 (1.14–1.34)
How well do you feel you understand your illness? 1.00 (0.92–1.08) 1.00 (0.92–1.09)
How much does your illness affect you emotionally? (e.g. does it make you angry,
scared, upset or depressed?)
1.34 (1.24–1.45) 1.36 (1.25–1.48)
aAdjusted for age, education and income.
bOdds ratio.
cConfidence interval.
Table 3. Odds ratio of patients’ beliefs about specific necessity and concerns about medicines in regard poor asthma control.
Univariate Multivariatec
ORa (95% CIb) OR (95% CI)
Necessity
My health is fully dependent on the asthma medication 2.85 (1.80–4.50) 2.89 (1.78–4.71)
Without asthma medication my life would be impossible 2.51 (1.60–3.93) 2.53 (1.56–4.12)
Without my asthma medication I would be very ill 2.75 (1.75–4.33) 2.69 (1.66–4.38)
My future health depends on my asthma medication 1.63 (1.02–2.60) 1.54 (0.94–2.54)
Controlling my asthma medication prevents health deterioration 1.00 (0.57–1.76) 0.91 (0.49–1.68)
Concerns
I am concerned by the need to constantly use my asthma medication 1.90 (1.20–3.01) 1.94 (1.19–3.17)
I am sometimes concerned by long term effects of my asthma medication 1.45 (0.92–2.27) 1.33 (0.82–2.15)
My asthma medication is incomprehensible to me 1.00 (0.58–1.72) 0.82 (0.45–1.47)
aOdds ratio.
bConfidence interval.
cAdjusted for age, education and income.
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hand found a high number of patients with inad-
equate asthma control, with slightly higher figures in
winter than in spring (74.4 versus 71%) [30].
Furthermore, a cross-sectional study performed in 29
countries of America, Europe and Asia on 7786 adults’
asthma reported that in Central and Eastern European
close to 70% of asthma patients experienced that their
disease limited their normal daily activities [8]. Finally,
the European Community Respiratory Health Survey II
reported that 85% of the asthmatic adults who had
used corticosteroids (ICS) in the last 12 months were
not able to achieve total control of the disease.
Among those who had not used ICSs in the past year,
the prevalence of uncontrolled asthma was 54% [29].
As shown in this and other studies, there is a
strong influence of beliefs about illness and treatment
on self-management of asthma [31]. Previous studies
have shown that individuals with asthma who believe
that their medication is necessary for their present
and future health or that it prevents exacerbation of
their disease are more likely to have their asthma
well controlled [32]. In contrast, individuals who are
concerned about their asthma medication are more
inclined to deviate from the prescribed treatment
[14,15,25]. Patients often make treatment choices
according to their own understanding and beliefs
about the illness and treatment [33]. Patients’ adher-
ence to medication is particularly influenced by the
way in which they evaluate their personal need for
medication relative to their concerns about potential
negative effects of taking it [21,33]. This is in line
with the results of our study indicating that asthma
patients concerned about their medications had a 2–3
fold higher probability to have poor asthma control.
Furthermore, a recent Australian study indicated that
personal health beliefs about control can undermine
adherence to medical and environmental remediation
advice and likely contributes to high rates of uncon-
trolled asthma [34].
In conclusion, our findings may have several prac-
tical applications in the care of asthma patients.
Existing questionnaires assessing beliefs of medication
necessity, cognitive or emotional illness perception
may be used to identify patients with poor asthma
control, in order to help them to identify problems of
poor control and offering better treatment solutions. If
these tools were integrated within the pulmonologist
practices where the vast majority of asthma patients
receive their initial disease diagnosis and treatment ini-
tiation, they could help in designing individualized
asthma treatment plans, and thus reduce the short
and long-term complications of asthma improving the
quality of life of asthma patients.
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